Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure

被引:108
作者
Janigan, DT
Hirsch, DJ
Klassen, GA
Macdonald, AS
机构
[1] Queen Elizabeth II Hlth Sci Ctr, Dept Pathol & Lab Med, Halifax, NS, Canada
[2] Queen Elizabeth II Hlth Sci Ctr, Dept Med, Halifax, NS, Canada
[3] Queen Elizabeth II Hlth Sci Ctr, Dept Surg, Halifax, NS, Canada
[4] Dalhousie Univ, Sch Med, Halifax, NS, Canada
关键词
chronic kidney failure; arterioles; pathological calcification (calcinosis); subcutaneous infarction; skin infarction; obesity; calciphylaxis;
D O I
10.1016/S0272-6386(00)70003-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Patients with chronic renal failure (CRF) are at increased risk for pathological calcifications because of Increased serum calcium-phosphorus products. A minority, including those undergoing dialysis, develop a syndrome of deep skin ulcerations in association with calcification of subcutaneous arterioles, The body distribution of the skin lesions may be proximal (central), distal (peripheral), or both. Since 1968, this syndrome has been called "calciphylaxis" in the belief that it is the human analogue of Selye's experimental models of tissue calcification. Our review emphasizes that this syndrome comprises two separate processes not found in calciphylaxis: calcification of subcutaneous arterioles and infarctions of subcutaneous adipose tissue (panniculus adiposus) and skin. The infarctions are acute and clinically dramatic, whereas the calcific arteriolopathy is preexistent, having developed slowly, sometimes over years, and silently Separating these two processes facilitates analyses of pathogenetic factors, such as those that target subcutaneous arterioles for calcification and those that interfere with blood flow through the calcified arterioles, sufficient in some patients to cause the infarctions, and of why obesity in CRF is a syndrome risk factor. This approach further helps to provide a much needed standardized definition of the syndrome, thereby facilitating comparisons of the results of such treatments as parathyroidectomy, anticoagulants, and phosphate binders. Finally, the separation shows why the application of such terms as calciphylaxis and calcifying panniculitis to this syndrome is inappropiate, (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 105 条
[1]
SYSTEMIC CALCIPHYLAXIS REVISITED [J].
ADROGUE, HJ ;
FRAZIER, MR ;
ZELUFF, B ;
SUKI, WN .
AMERICAN JOURNAL OF NEPHROLOGY, 1981, 1 (3-4) :177-183
[2]
ANDERSON DC, 1968, LANCET, V2, P323
[3]
Anderson HC, 1993, HDB EXPT PHARM, P267, DOI DOI 10.1007/978-3-642-77991-6_8
[4]
Calciphylaxis in patients on hemodialysis: A prevalence study [J].
Angelis, M ;
Wong, LL ;
Myers, SA ;
Wong, LM .
SURGERY, 1997, 122 (06) :1083-1089
[5]
A CASE OF CALCIPHYLAXIS - CASE-REPORT [J].
ASMUNDSSON, P ;
ELIASSON, GJ ;
PORDARSON, H .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1988, 22 (02) :155-157
[6]
BARGMAN JM, 1995, J RHEUMATOL, V22, P5
[7]
BAUER KA, 1993, ARCH DERMATOL, V129, P766, DOI 10.1001/archderm.129.6.766
[8]
A case control study of proximal calciphylaxis [J].
Bleyer, AJ ;
Choi, M ;
Igwemezie, B ;
de la Torre, E ;
White, WL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (03) :376-383
[9]
HYPERPARATHYROIDISM [J].
BOGDONOFF, MD ;
WOODS, AH ;
WHITE, JE ;
ENGEL, FL .
AMERICAN JOURNAL OF MEDICINE, 1956, 21 (04) :583-595
[10]
CALCIPHYLAXIS - EXTENSIVE CUTANEOUS NECROSES WITH VASCULAR AND SUBCUTANEOUS CALCINOSIS IN PATIENTS WITH CHRONIC RENAL-FAILURE - CASE-REPORT [J].
BOURLOND, A ;
EGGERS, S ;
WILLOCX, D ;
LOUTE, G ;
GHYSEN, J .
DERMATOLOGICA, 1989, 179 (03) :165-170